[What should be the target of therapy in the adult-onset diabetes mellitus?].
Yki-Järvinen
H
H
Helsingin yliopisto, sisätautien laitos PL 340, 00029 HYKS. ykijarvi@helsinki.fi
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D002317:Cardiovascular Agents / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy* / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D002317:Cardiovascular Agents; D007004:Hypoglycemic Agents